A novel DNA enzyme reduces glycosaminoglycan chains in the glial scar and allows microtransplanted dorsal root ganglia axons to regenerate beyond lesions in the spinal cord.

PubWeight™: 1.21‹?› | Rank: Top 10%

🔗 View Article (PMID 14960611)

Published in J Neurosci on February 11, 2004

Authors

Barbara Grimpe1, Jerry Silver

Author Affiliations

1: Case Western Reserve University, School of Medicine, Department of Neurosciences, Cleveland, Ohio 44106, USA. bxg15@po.cwru.edu

Articles citing this

CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure. Exp Neurol (2007) 4.00

Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J Exp Med (2005) 2.51

Extracellular regulators of axonal growth in the adult central nervous system. Philos Trans R Soc Lond B Biol Sci (2006) 2.10

Functional regeneration beyond the glial scar. Exp Neurol (2014) 1.79

Axonal growth therapeutics: regeneration or sprouting or plasticity? Trends Neurosci (2008) 1.66

Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors. J Neurosci (2011) 1.52

Neurogenesis of corticospinal motor neurons extending spinal projections in adult mice. Proc Natl Acad Sci U S A (2004) 1.37

Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3. Exp Neurol (2007) 1.35

Role of the lesion scar in the response to damage and repair of the central nervous system. Cell Tissue Res (2012) 1.21

Pathophysiology of the brain extracellular matrix: a new target for remyelination. Nat Rev Neurosci (2013) 1.15

Remyelination therapy for multiple sclerosis. Neurotherapeutics (2013) 1.08

A chemical screen identifies novel compounds that overcome glial-mediated inhibition of neuronal regeneration. J Neurosci (2010) 1.05

Recent therapeutic strategies for spinal cord injury treatment: possible role of stem cells. Neurosurg Rev (2012) 1.04

Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies. Am J Pathol (2007) 1.01

Alterations in chondroitin sulfate proteoglycan expression occur both at and far from the site of spinal contusion injury. Exp Neurol (2011) 1.00

Chondroitin sulphate N-acetylgalactosaminyl-transferase-1 inhibits recovery from neural injury. Nat Commun (2013) 1.00

Using motor behavior during an early critical period to restore skilled limb movement after damage to the corticospinal system during development. J Neurosci (2012) 0.98

Modification of N-glycosylation sites allows secretion of bacterial chondroitinase ABC from mammalian cells. J Biotechnol (2009) 0.90

A novel biological function for CD44 in axon growth of retinal ganglion cells identified by a bioinformatics approach. J Neurochem (2007) 0.87

Benefit of chondroitinase ABC on sensory axon regeneration in a laceration model of spinal cord injury in the rat. Surg Neurol (2008) 0.86

Molecular mechanisms of scar-sourced axon growth inhibitors. Brain Res (2014) 0.83

The effects of proteoglycan surface patterning on neuronal pathfinding. Materwiss Werksttech (2007) 0.83

Catalytic nucleic acid enzymes for the study and development of therapies in the central nervous system: Review Article. Gene Ther Mol Biol (2005) 0.82

Epidermal growth factor receptor inhibitor ameliorates excessive astrogliosis and improves the regeneration microenvironment and functional recovery in adult rats following spinal cord injury. J Neuroinflammation (2014) 0.81

Chondroitinase enhances cortical map plasticity and increases functionally active sprouting axons after brain injury. J Neurotrauma (2013) 0.81

Need for a paradigm shift in therapeutic approaches to CNS injury. Expert Rev Neurother (2012) 0.80

Chondroitin sulfate proteoglycans in the nervous system: inhibitors to repair. Biomed Res Int (2014) 0.79

In the presence of danger: The extracellular matrix defensive response to central nervous system injury. Neural Regen Res (2014) 0.78

Pharmacological Suppression of CNS Scarring by Deferoxamine Reduces Lesion Volume and Increases Regeneration in an In Vitro Model for Astroglial-Fibrotic Scarring and in Rat Spinal Cord Injury In Vivo. PLoS One (2015) 0.78

Evaluation of the Combination of Methylprednisolone and Tranilast after Spinal Cord Injury in Rat Models. J Korean Neurosurg Soc (2016) 0.77

Lentiviral Delivery of miR-133b Improves Functional Recovery After Spinal Cord Injury in Mice. Mol Neurobiol (2016) 0.76

Deoxyribozymes: new therapeutics to treat central nervous system disorders. Front Mol Neurosci (2011) 0.75

Gene delivery to overcome astrocyte inhibition of axonal growth: an in vitro model of the glial scar. Biotechnol Bioeng (2012) 0.75

Rewiring the spinal cord: Direct and indirect strategies. Neurosci Lett (2016) 0.75

Articles by these authors

Functional regeneration of respiratory pathways after spinal cord injury. Nature (2011) 4.07

CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure. Exp Neurol (2007) 4.00

Combining an autologous peripheral nervous system "bridge" and matrix modification by chondroitinase allows robust, functional regeneration beyond a hemisection lesion of the adult rat spinal cord. J Neurosci (2006) 3.21

Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxiety-like and aggressive behavior. Neuron (2003) 3.19

PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration. Science (2009) 2.84

The role of extracellular matrix in CNS regeneration. Curr Opin Neurobiol (2007) 2.77

Nerve regeneration restores supraspinal control of bladder function after complete spinal cord injury. J Neurosci (2013) 2.43

Another barrier to regeneration in the CNS: activated macrophages induce extensive retraction of dystrophic axons through direct physical interactions. J Neurosci (2008) 2.20

Studies on the development and behavior of the dystrophic growth cone, the hallmark of regeneration failure, in an in vitro model of the glial scar and after spinal cord injury. J Neurosci (2004) 2.10

Chondroitinase ABC digestion of the perineuronal net promotes functional collateral sprouting in the cuneate nucleus after cervical spinal cord injury. J Neurosci (2006) 2.00

Chronic enhancement of the intrinsic growth capacity of sensory neurons combined with the degradation of inhibitory proteoglycans allows functional regeneration of sensory axons through the dorsal root entry zone in the mammalian spinal cord. J Neurosci (2005) 1.82

Overcoming macrophage-mediated axonal dieback following CNS injury. J Neurosci (2009) 1.81

Light-induced rescue of breathing after spinal cord injury. J Neurosci (2008) 1.68

Adult NG2+ cells are permissive to neurite outgrowth and stabilize sensory axons during macrophage-induced axonal dieback after spinal cord injury. J Neurosci (2010) 1.61

Astrocyte-associated fibronectin is critical for axonal regeneration in adult white matter. J Neurosci (2004) 1.54

Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors. J Neurosci (2011) 1.52

Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3. Exp Neurol (2007) 1.35

Multipotent adult progenitor cells prevent macrophage-mediated axonal dieback and promote regrowth after spinal cord injury. J Neurosci (2011) 1.25

Chondroitin sulfate proteoglycans potently inhibit invasion and serve as a central organizer of the brain tumor microenvironment. J Neurosci (2013) 1.20

The role of proteoglycans in Schwann cell/astrocyte interactions and in regeneration failure at PNS/CNS interfaces. Mol Cell Neurosci (2005) 1.08

Precursors of neurons, neuroglia, and ependymal cells in the CNS: what are they? Where are they from? How do they get where they are going? Glia (2003) 1.04

The extracellular matrix in axon regeneration. Prog Brain Res (2002) 1.02

The unusual response of serotonergic neurons after CNS Injury: lack of axonal dieback and enhanced sprouting within the inhibitory environment of the glial scar. J Neurosci (2011) 1.00

Immature astrocytes promote CNS axonal regeneration when combined with chondroitinase ABC. Dev Neurobiol (2010) 0.99

The critical role of basement membrane-independent laminin gamma 1 chain during axon regeneration in the CNS. J Neurosci (2002) 0.98

Demonstrating efficacy in preclinical studies of cellular therapies for spinal cord injury - how much is enough? Exp Neurol (2013) 0.94

Electrical stimulation of intact peripheral sensory axons in rats promotes outgrowth of their central projections. Exp Neurol (2007) 0.94

Serotonergic neurons migrate radially through the neuroepithelium by dynamin-mediated somal translocation. J Neurosci (2010) 0.94

Treatments to restore respiratory function after spinal cord injury and their implications for regeneration, plasticity and adaptation. Exp Neurol (2011) 0.92

Multipotent embryonic spinal cord stem cells expanded by endothelial factors and Shh/RA promote functional recovery after spinal cord injury. Exp Neurol (2007) 0.89

A combination immunomodulatory treatment promotes neuroprotection and locomotor recovery after contusion SCI. Exp Neurol (2010) 0.88

Shedding light on restoring respiratory function after spinal cord injury. Front Mol Neurosci (2009) 0.84

The effect of long-term release of Shh from implanted biodegradable microspheres on recovery from spinal cord injury in mice. Biomaterials (2012) 0.83

Fibronectin inhibits chronic pain development after spinal cord injury. J Neurotrauma (2012) 0.83

Keratan sulfate proteoglycan phosphacan regulates mossy fiber outgrowth and regeneration. J Neurosci (2004) 0.80

Extravascular CX3CR1+ cells extend intravascular dendritic processes into intact central nervous system vessel lumen. Microsc Microanal (2013) 0.79

Oncomodulin affords limited regeneration to injured sensory axons in vitro and in vivo. Exp Neurol (2011) 0.77

Discovery of 1,2,3-Triazole Derivatives for Multimodality PET/CT/Cryoimaging of Myelination in the Central Nervous System. J Med Chem (2017) 0.75

831 Prelesion but Not Postlesion Inflammation Plus Proteoglycan Degradation Results in Functional Regeneration. Neurosurgery (2005) 0.75